1. Home
  2. CVLT vs DNTH Comparison

CVLT vs DNTH Comparison

Compare CVLT & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commvault Systems Inc.

CVLT

Commvault Systems Inc.

HOLD

Current Price

$168.49

Market Cap

6.8B

Sector

Technology

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$77.61

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVLT
DNTH
Founded
1996
2015
Country
United States
United States
Employees
3300
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.9B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
CVLT
DNTH
Price
$168.49
$77.61
Analyst Decision
Buy
Strong Buy
Analyst Count
19
17
Target Price
★ $163.49
$140.80
AVG Volume (30 Days)
497.2K
★ 844.2K
Earning Date
10-27-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.50
N/A
Revenue
★ $1,183,690,000.00
$2,036,000.00
Revenue This Year
$10.32
N/A
Revenue Next Year
$11.31
N/A
P/E Ratio
$328.55
★ N/A
Revenue Growth
★ 18.89
N/A
52 Week Low
$71.75
$32.28
52 Week High
$175.03
$117.88

Technical Indicators

Market Signals
Indicator
CVLT
DNTH
Relative Strength Index (RSI) 65.79 32.12
Support Level $127.70 $75.50
Resistance Level N/A $91.36
Average True Range (ATR) 6.26 4.15
MACD 0.73 0.26
Stochastic Oscillator 93.60 36.00

Price Performance

Historical Comparison
CVLT
DNTH

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: